![Online Wholesale Supply of Medicine, Medical Supplies, OTC | RetailerShaktihttps://www.retailershakti.com/ Online Wholesale Supply of Medicine, Medical Supplies, OTC | RetailerShaktihttps://www.retailershakti.com/](https://res.retailershakti.com/incom/images/product/small/retarel-1406056613-10005722.jpg)
Online Wholesale Supply of Medicine, Medical Supplies, OTC | RetailerShaktihttps://www.retailershakti.com/
![Table 1 from INFLUENCE OF TOPICAL RETAPAMULIN (1%) OINTMENT, SOFINOX- RD CREAM, SOFINOX CREAM (2%), ZINC FUSIDATE CREAM (2%) AND ZINC FUSIDATE OINTMENT (2%) ON NASAL MUCOSAL SURFACE SAFETY IN NEW ZEALAND ALBINO RABBITS | Semantic Scholar Table 1 from INFLUENCE OF TOPICAL RETAPAMULIN (1%) OINTMENT, SOFINOX- RD CREAM, SOFINOX CREAM (2%), ZINC FUSIDATE CREAM (2%) AND ZINC FUSIDATE OINTMENT (2%) ON NASAL MUCOSAL SURFACE SAFETY IN NEW ZEALAND ALBINO RABBITS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/72de0259243567483e1be6c554e960465e1ee65e/3-Figure2-1.png)
Table 1 from INFLUENCE OF TOPICAL RETAPAMULIN (1%) OINTMENT, SOFINOX- RD CREAM, SOFINOX CREAM (2%), ZINC FUSIDATE CREAM (2%) AND ZINC FUSIDATE OINTMENT (2%) ON NASAL MUCOSAL SURFACE SAFETY IN NEW ZEALAND ALBINO RABBITS | Semantic Scholar
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALTABAX safely and effec
![These highlights do not include all the information needed to use ALTABAX safely and effectively. See full prescribing information for ALTABAX. ALTABAX (retapamulin ointment), for topical use Initial U.S. Approval: 2007 These highlights do not include all the information needed to use ALTABAX safely and effectively. See full prescribing information for ALTABAX. ALTABAX (retapamulin ointment), for topical use Initial U.S. Approval: 2007](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=altabax-04.jpg&id=578933)
These highlights do not include all the information needed to use ALTABAX safely and effectively. See full prescribing information for ALTABAX. ALTABAX (retapamulin ointment), for topical use Initial U.S. Approval: 2007
![Figure 3 from INFLUENCE OF TOPICAL RETAPAMULIN (1%) OINTMENT, SOFINOX- RD CREAM, SOFINOX CREAM (2%), ZINC FUSIDATE CREAM (2%) AND ZINC FUSIDATE OINTMENT (2%) ON NASAL MUCOSAL SURFACE SAFETY IN NEW ZEALAND ALBINO RABBITS | Semantic Scholar Figure 3 from INFLUENCE OF TOPICAL RETAPAMULIN (1%) OINTMENT, SOFINOX- RD CREAM, SOFINOX CREAM (2%), ZINC FUSIDATE CREAM (2%) AND ZINC FUSIDATE OINTMENT (2%) ON NASAL MUCOSAL SURFACE SAFETY IN NEW ZEALAND ALBINO RABBITS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/72de0259243567483e1be6c554e960465e1ee65e/3-Figure3-1.png)
Figure 3 from INFLUENCE OF TOPICAL RETAPAMULIN (1%) OINTMENT, SOFINOX- RD CREAM, SOFINOX CREAM (2%), ZINC FUSIDATE CREAM (2%) AND ZINC FUSIDATE OINTMENT (2%) ON NASAL MUCOSAL SURFACE SAFETY IN NEW ZEALAND ALBINO RABBITS | Semantic Scholar
![Topical Retapamulin Ointment, 1%, versus Sodium Fusidate Ointment, 2%, for Impetigo: A Randomized, Observer-Blinded, Noninferiority Study | Semantic Scholar Topical Retapamulin Ointment, 1%, versus Sodium Fusidate Ointment, 2%, for Impetigo: A Randomized, Observer-Blinded, Noninferiority Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f7149eeaff393c97dcdec904402b5c6cb1a7a640/5-Figure2-1.png)